Article
Unperturbed Immune Function despite Mutation of C-Terminal Tyrosines in Syk Previously Implicated in Signaling and Activity Regulation.
Molecular and cellular biology - 1 Nov 2017
Weis Vanessa, Königsberger Sebastian, Amler Susanne, Wienands Jürgen, Kiefer Friedemann
Abstract excerpt
The nonreceptor tyrosine kinase Syk, a central regulator of immune cell differentiation and activation, is a promising drug target for treatment of leukemia and allergic and inflammatory diseases. The clinical failure of Syk inhibitors underscores the importance of understanding the regulation of Syk function and activity. A series of previous studies emphasized the importance of three C-terminal tyrosines in Syk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
